Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Healthtrust
AstraZeneca
Johnson and Johnson
US Army
McKesson
Teva
Covington
Fuji

Generated: April 27, 2018

DrugPatentWatch Database Preview

GLUCOTROL Drug Profile

« Back to Dashboard

When do Glucotrol patents expire, and what generic alternatives are available?

Glucotrol is a drug marketed by Pfizer and is included in two NDAs. There is one patent protecting this drug.

The generic ingredient in GLUCOTROL is glipizide. There are eighteen drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the glipizide profile page.
Drug patent expirations by year for GLUCOTROL
Pharmacology for GLUCOTROL
Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Medical Subject Heading (MeSH) Categories for GLUCOTROL
Synonyms for GLUCOTROL
094G619
1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea
1-cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea
1-cyclohexyl-3-(4-(2-(2-methylpyrazine-5-carboxamido)ethyl)phenylsulfonyl)urea
1-cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]urea
1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea
172964-66-8
29094-61-9
29094-66-4
38777-27-4
AB0012143
AC-15789
AC1L1G0Z
AC1Q2OG0
AKOS005564405
Aldiab
Alphapharm Brand of Glipizide
AN-15826
ANW-41980
API0002842
BBL028143
BC209538
BDBM50012956
BG0209
BIDD:GT0476
Bio-0161
Bio1_000074
Bio1_000563
Bio1_001052
Bio2_000069
Bio2_000549
BPBio1_000224
BRD-K12219985-001-04-8
BRN 0903495
BSPBio_000202
BSPBio_001349
C-22417
C21H27N5O4S
CAS-29094-61-9
CBiol_001788
CC-28982
CCG-204710
CHEBI:5384
CHEMBL1073
CP 28,720
CP 28720
CP-28,720
CP-28720
CPD000058455
CS-2239
CTK8B3212
D00335
D0Z4SB
DB01067
Digrin
Dipazide
DR002755
DSSTox_CID_20676
DSSTox_GSID_40676
DSSTox_RID_79535
DTXSID0040676
EINECS 249-427-6
EU-0100621
FT-0626714
FT-0659737
G-117
G0369
Glibenese
Glibenese Brand of Glipizide
Glibetin
Glican
Glide
Glidiab
Glidiazinamide
Glipid
Glipizibe
glipizid
Glipizida
Glipizida [INN-Spanish]
glipizide
Glipizide (Glucotrol)
Glipizide (USP/INN)
Glipizide [USAN:BAN:INN]
Glipizide [USAN:USP:INN:BAN]
Glipizide Extended-Release Tablets
Glipizide Kenfarma Brand
Glipizide, European Pharmacopoeia (EP) Reference Standard
Glipizide, pharmaceutical secondary standard; traceable to USP, PhEur
Glipizide, solid
Glipizide, United States Pharmacopeia (USP) Reference Standard
Glipizidum
Glipizidum [INN-Latin]
Gluco-Rite
Glucolip
Glucotrol (TN)
Glucotrol XL
Glucotrol XL, Glucotrol, Glipizide
Glucozide
Glupitel
Glupizide
Glyde
Glydiazinamide
Glypidizine
GTPL6821
HE332283
HMS1361D11
HMS1568K04
HMS1791D11
HMS1989D11
HMS2089C21
HMS2093J09
HMS2095K04
HMS2233N11
HMS3259K12
HMS3261N04
HMS3369L12
HMS3402D11
HMS3655G04
HY-B0254
I06-0186
I06-1985
IDI1_033819
K 4024
K-4024
K4024
KB-52251
KBio2_000069
KBio2_002637
KBio2_005205
KBio3_000137
KBio3_000138
KBioGR_000069
KBioSS_000069
Kenfarma Brand of Glipizide
KS-1068
Lacer Brand of Glipizide
Lilly Brand of Glipizide
Lopac-G-117
Lopac0_000621
LP00621
LS-159679
MCULE-5142805548
Melizide
Metaglip
Metaglip (Salt/Mix)
MFCD00072159
Mindiab
Minidab
Minidiab
Minodiab
MLS000069386
MLS001148176
MolPort-002-885-830
N-(2-[4-(([(Cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-5-methyl-2-pyrazinecarboxamide
N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide
N-(4-(.beta.-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea
N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea
N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-5-methylpyrazine-2-carboxamide
N-(4-[N-(cyclohexylcarbamoyl)sulfamoyl]phenethyl)-5-methylpyrazine-2-carboxamide
N-[2-(4-{[(cyclohexylamino)carbonylamino]sulfonyl}phenyl)ethyl](5-methylpyrazi n-2-yl)carboxamide
N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide
N-[4-(3-Cyclohexylureidosulfonyl)phenethyl]-5-methyl-2-pyrazinecarboxamide
N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-N'-cyclohexylurea
Napizide
NC00564
NCGC00015462-01
NCGC00015462-02
NCGC00015462-03
NCGC00015462-04
NCGC00015462-05
NCGC00015462-06
NCGC00015462-07
NCGC00015462-08
NCGC00015462-09
NCGC00015462-10
NCGC00015462-11
NCGC00015462-12
NCGC00015462-14
NCGC00016802-01
NCGC00023748-03
NCGC00023748-04
NCGC00023748-05
NCGC00023748-06
NCGC00023748-07
NCGC00255522-01
NCGC00261306-01
NSC-759120
NSC759120
Opera_ID_1908
Ozidia
Pfizer Brand 2 of Glipizide
PfizerBrand 1 of Glipizide
Pharmakon1600-01505433
Prestwick_242
Prestwick0_000131
Prestwick1_000131
Prestwick2_000131
Prestwick3_000131
Pyrazinecarboxamide, N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-
Pyrazinecarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-
s1715
SAM002564210
Samarium(III) ionophore I
SBI-0050603.P002
SC-13933
SCHEMBL17094
Semiglynase
SMR000058455
SPBio_002141
SR-01000000010
SR-01000000010-2
ST50826363
STK631952
Sucrazide
TC-063559
TK 1320
TL8006447
Tox21_110156
Tox21_110156_1
Tox21_301834
Tox21_500621
UNII-X7WDT95N5C
Urea, 1-cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)-
W-107005
X7WDT95N5C
Z1880962274
ZINC537795
ZJJXGWJIGJFDTL-UHFFFAOYSA-N

US Patents and Regulatory Information for GLUCOTROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer GLUCOTROL glipizide TABLET;ORAL 017783-003 May 11, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-003 Aug 10, 1999 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer GLUCOTROL glipizide TABLET;ORAL 017783-001 May 8, 1984 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer GLUCOTROL glipizide TABLET;ORAL 017783-002 May 8, 1984 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for GLUCOTROL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GLUCOTROL glipizide TABLET;ORAL 017783-001 May 8, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer GLUCOTROL glipizide TABLET;ORAL 017783-002 May 8, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Harvard Business School
Express Scripts
Julphar
Fish and Richardson
Colorcon
Citi
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.